Liquid Biopsy Market 2020: Current Trends, Product Types, Application, Key Services, Advance Research, Segmentation and Opportunities, Forecast 2025 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Liquid Biopsy Market 2020: Current Trends, Product Types, Application, Key Services, Advance Research, Segmentation and Opportunities, Forecast 2025

Description:

Increasing cancer prevalence, preference for non-invasive diagnostics techniques and shift towards personalized medicines are the key factors driving the global liquid biopsy market. – PowerPoint PPT presentation

Number of Views:1
Date added: 17 September 2020
Slides: 7
Provided by: Thomashinds
Category:
Tags:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Liquid Biopsy Market 2020: Current Trends, Product Types, Application, Key Services, Advance Research, Segmentation and Opportunities, Forecast 2025


1
Global Liquid Biopsy Market
  • Size 2018, by Application (Early Cancer
    Screening, Therapy Selection, Treatment
    Monitoring, Risk of Recurrence), Cancer Type
    (Lung Cancer, Breast Cancer, Colorectal Cancer,
    Prostate Cancer, Other Cancers) Circulating
    Biomarkers (Circulating Tumor Cells, Circulating
    Tumor DNA, Other Circulating Biomarkers), Region
    and Forecast 2019 to 2025

Single Use License US 4400
Request Sample
2
Global Liquid Biopsy Market To Grow From USD 812
Million In 2018 To USD 6,014 Million By 2025
  • The global liquid biopsy market is anticipated to
    reach USD 6,014.2 million by 2025, growing at a
    CAGR of 33.4. Increasing cancer prevalence is a
    prime factor driving the global liquid biopsy
    market.
  • Adroit Market Research report on global liquid
    biopsy market gives a holistic view of the market
    from 2017 to 2025, which includes factors such as
    market drivers, restraints, opportunities, and
    challenges. The market has been studied for
    historic year 2017, with the base year of
    estimation as 2018 and forecast from 2019 to
    2025. The report covers the current status and
    future traits of the market at global as well as
    country level along with the depiction of the
    industrys value chain. In addition, the study
    also assesses the market based on Porter's five
    forces analysis. Noticeable players serving in
    the global liquid biopsy market have also been
    studied in detail.
  • Liquid biopsy is a minimally invasive technique
    that can identify molecular biomarkers in blood
    and other body fluids. Mainly used for cancer,
    liquid biopsies allow for detection and analysis
    of circulating tumour material (cells or DNA)
    shed into the blood from the primary tumour and
    from metastatic sites. Current clinical
    applications of liquid biopsy include patient
    stratification and therapy selection, monitoring
    treatment response and drug resistance, disease
    prognosis and detection of disease recurrence.
  • The global liquid biopsy market has been
    segmented based on applications, cancer type, and
    circulating biomarker types. Based on
    applications, the market is broken down into
    early cancer screening, therapy selection,
    treatment monitoring and risk of recurrence.
    Early cancer screening is expected to account
    nearly 50 market share by 2025.

3
Global Liquid Biopsy Market To Grow From USD 812
Million In 2018 To USD 6,014 Million By 2025
  • Asia Pacific is anticipated to be the fastest
    growing market through the forecast period. In
    this region rising income, increased
    urbanization, growing cancer cases, and
    governments focus on healthcare facilities is
    driving the liquid biopsy market. However, there
    are substantial barriers to liquid biopsy
    adoption. A number of assays intended on
    high-cost next generation sequencing technology
    are not reimbursed, obstructing market uptake.
    Moreover, cost of the procedure is facilitating
    access to a larger population in India, Japan and
    China, which depend heavily on out-of-pocket
    expenditure. Worldwide, in the race of active
    clinical trials in liquid biopsy East Asia ranks
    second, while China bangs the maximum number of
    trials. Therefore, it is advised that companies
    must design and develop randomized controlled
    trials and inclusion in guidelines to encourage
    broader acceptance and favorable payer coverage
    in Asia Pacific.
  • Major players operating in the global liquid
    biopsy market are Biocept, Inc., Qiagen N.V.,
    Roche Diagnostics, Bio-Rad Laboratories, Inc.,
    Myriad Genetics, Inc., Menarini-Silicon
    Biosystems, Trovagene, Inc., Guardant Health,
    Inc. and Genomic Health, Inc. among others.
  • Browse the complete report on _at_
    https//www.adroitmarketresearch.com/industry-repo
    rts/liquid-biopsy-market

4
Key segments of the global liquid biopsy market
  • Application Overview, 2017-2025 (USD Million)
  • Early cancer screening
  • Therapy selection
  • Treatment monitoring
  • Risk of recurrence
  • Cancer Type Overview, 2017-2025 (USD Million)
  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Other cancers
  • Circulating Biomarker Overview, 2017-2025 (USD
    Million)
  • Circulating tumor cells (CTCs)
  • Circulating tumor DNA (ctDNA)
  • Other circulating biomarkers

5
Key segments of the global liquid biopsy market
  • Regional Overview, 2015-2025 (USD million) (Kilo
    tons)
  • North America
  • Europe
  • Asia Pacific
  • Central South America
  • Middle East Africa
  • Purchase a single user copy of the global liquid
    biopsy market report_at_ https//adroitmarketresearch
    .com/researchreport/purchase/1413

6
About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email sales_at_adroitmarketresearch.com
About PowerShow.com